RT Journal Article SR Electronic T1 Prescribing for Women in Corrections JF Journal of the American Academy of Psychiatry and the Law Online JO J Am Acad Psychiatry Law FD American Academy of Psychiatry and the Law SP 476 OP 485 DO 10.29158/JAAPL.003885-19 VO 47 IS 4 A1 Friedman, Susan Hatters A1 Tamburello, Anthony C. A1 Kaempf, Aimee A1 Hall, Ryan C.W. YR 2019 UL http://jaapl.org/content/47/4/476.abstract AB Prescribing for women in jails and prisons requires special consideration and should be informed by extant evidence. Incarcerated women have higher rates of mental illness than both females in the community and incarcerated men. Medication administration concerns that may disproportionately affect female prisoners include drug–drug interactions with contraceptives, intermittent dosing schedules, and concerns about metabolic side effects. Further, pregnancy, lactation, and menopause may all affect medication choices. Incarcerated women frequently have comorbid mental illness, substance use disorders, and personality disorders. Finally, specific disorders, such as posttraumatic stress disorder, are more common in this population and merit special consideration for recognition and treatment.